is sitagliptin a glp-1 for type 2 diabetes mellitus | DPP 4 inhibitor GLP-1-RA and DPP-4 inhibitors in

This article is based on scientific evidence, written by experts and fact checked by our trained editorial staff

Until recently, the only effective treatment for obesity was bariatric surgery, and a century of drug development for obesity can be essentially described as a failure until now

Clinical trials conducted on Wegovy patients revealed that approximately 44 percent reported nausea, while almost 25 percent reported vomiting, both of which are common symptoms of gastroparesis

Recent data from insurance claims indicates that 30% of patients stop treatment within a month, well before any clinically meaningful results could be achieved